IONS
Ionis Pharmaceuticals IncCompany with tickers: IONS
Market Cap
$12.95B
Shares Outstanding
165,262,556
CIK
874015
CUSIP
462222100
13F Activity (30d)
33 filings
7 filers
Website
Visit website
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Peter N. Reikes | member of the Company's Board | Appointed | 2026-06-08 |
| Ludwig N. Hantson | member of the Company's Board | Appointed | 2026-06-08 |